Induction Healthcare Group PLC provides software to healthcare professionals in the United Kingdom, rest of Europe, the United States, and internationally. More Details
Flawless balance sheet and overvalued.
Share Price & News
How has Induction Healthcare Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: INHC is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: INHC's weekly volatility (6%) has been stable over the past year.
7 Day Return
GB Healthcare Services
1 Year Return
GB Healthcare Services
Return vs Industry: INHC underperformed the UK Healthcare Services industry which returned 64.7% over the past year.
Return vs Market: INHC underperformed the UK Market which returned 27.6% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Induction Healthcare Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StUpdate: Induction Healthcare Group (LON:INHC) Stock Gained 18% In The Last Year
11 months ago | Simply Wall StWe're Not Worried About Induction Healthcare Group's (LON:INHC) Cash Burn
1 year ago | Simply Wall StWe Think Induction Healthcare Group (LON:INHC) Can Afford To Drive Business Growth
Is Induction Healthcare Group undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate INHC's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate INHC's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: INHC is unprofitable, so we can't compare its PE Ratio to the European Healthcare Services industry average.
PE vs Market: INHC is unprofitable, so we can't compare its PE Ratio to the UK market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate INHC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: INHC is good value based on its PB Ratio (2x) compared to the GB Healthcare Services industry average (6.4x).
How is Induction Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Induction Healthcare Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Induction Healthcare Group performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: INHC is currently unprofitable.
Growing Profit Margin: INHC is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if INHC's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare INHC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: INHC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (13.1%).
Return on Equity
High ROE: INHC has a negative Return on Equity (-21.99%), as it is currently unprofitable.
How is Induction Healthcare Group's financial position?
Financial Position Analysis
Short Term Liabilities: INHC's short term assets (£5.6M) exceed its short term liabilities (£1.1M).
Long Term Liabilities: INHC's short term assets (£5.6M) exceed its long term liabilities (£1.4M).
Debt to Equity History and Analysis
Debt Level: INHC is debt free.
Reducing Debt: INHC had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: INHC has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: INHC has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 43.3% each year.
What is Induction Healthcare Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate INHC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate INHC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if INHC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if INHC's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of INHC's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Dr. Hugo Stephenson, M. D., is Interim Head of Product/Development at Induction Healthcare Group PLC since October 2019 and serves as its Joint Chief Executive Officer since March 02, 2020. Dr. Stephenson ...
CEO Compensation Analysis
Compensation vs Market: Hugo's total compensation ($USD146.81K) is below average for companies of similar size in the UK market ($USD338.89K).
Compensation vs Earnings: Insufficient data to compare Hugo's compensation with company performance.
Experienced Management: INHC's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Experienced Board: INHC's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 41.9%.
Induction Healthcare Group PLC's company bio, employee growth, exchange listings and data sources
- Name: Induction Healthcare Group PLC
- Ticker: INHC
- Exchange: AIM
- Founded: 2019
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: UK£41.840m
- Shares outstanding: 42.05m
- Website: https://www.inductionhealthcare.com
Number of Employees
- Induction Healthcare Group PLC
- 20 St. Dunstan’s Hill
- Greater London
- EC3R 8HL
- United Kingdom
Induction Healthcare Group PLC provides software to healthcare professionals in the United Kingdom, rest of Europe, the United States, and internationally. It offers Induction Switch, a communication and s...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/16 18:54|
|End of Day Share Price||2021/05/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.